Skip to main content
Erschienen in:

14.02.2021 | Original Article

A Prospective Study to Elucidate the Efficacy of 4 Oral Prednisolone Regimens in Acute Acoustic Trauma

verfasst von: Kamalpreet Singh, Aswini Gude, Amrindarjeet Kour, Mohan Raghav Guthikonda, Awadhesh Kumar Mishra, Arun Gupta

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Noise induced hearing loss affects around 5% of the population and acoustic trauma to military personnel accounts for 30% of all injuries inflicted during active service. Initial treatment for acoustic trauma involves administration of steroids, however there are no studies regarding oral steroid regimens for best outcomes. Comparing and elucidating the benefits of four oral steroid regimens on hearing gain in patients with acute acoustic trauma. A prospective study of 4 different steroid regimens was done in 200 soldiers from July 2014 – July 2020. In the first group, oral Prednisolone 60 mg was administered for 6 days, in the second group for 8 days, in the third group for 10 days and in the fourth group for 12 days. Medication was tapered over the next 5 days in all the groups. Data analysed included demographics, Pure Tone Audiograms at admission and at 4 weeks, time of reporting to hospital, onset of treatment and type of treatment given. Multivariate linear regression model was done to consider the risk factors responsible for average hearing gain at all pure tones. Box-and-whisker plot, Mann–Whitney-Wilcoxon test, Kruskal Wallis test, Reciever Operating Characteristic curve were used to analyse the independent samples. p value of < 0.05 was considered statistically significant. Age, time of onset of prednisolone therapy and acoustic trauma due to blast or gunshot injury did not show correlation (R2 = 0.01, 0.01 and 0.35 respectively and p = 0.09, 0.71, 0.80 respectively). Prednisolone therapy, average initial hearing at pure tones were considered as factors responsible for hearing gain as they showed correlation (R2 = 0.22, and 0.34 respectively and p < 0.001 and < 0.01 respectively). Significant hearing gain was found in all groups. The hearing gain was statistically better in group 3 and 4 as compared to group 1 and 2. There was no statistically significant difference in hearing gain between groups 3 and 4. So there was no additional advantage of giving 60 mg oral prednisolone for more than 10 days. The best oral prednisolone regimen recommended is 60 mg/day for 10 days which is tapered over the next 5 days.
Literatur
1.
Zurück zum Zitat Psillas G, Pavlidis P, Karvelis I, Kekes G, Vital V, Constantinidis J (2008) Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise. Eur Arch Otorhinolaryngol 265:1465–1469CrossRef Psillas G, Pavlidis P, Karvelis I, Kekes G, Vital V, Constantinidis J (2008) Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise. Eur Arch Otorhinolaryngol 265:1465–1469CrossRef
2.
Zurück zum Zitat Daniel E (2007) Noise and hearing loss: a review. J Sch Health 77:225–231CrossRef Daniel E (2007) Noise and hearing loss: a review. J Sch Health 77:225–231CrossRef
3.
Zurück zum Zitat Yamashita D, Jiang HY, Schacht J et al (2004) Delayed production of free radicals following noise exposure. Brain Res 1019:201–209CrossRef Yamashita D, Jiang HY, Schacht J et al (2004) Delayed production of free radicals following noise exposure. Brain Res 1019:201–209CrossRef
4.
Zurück zum Zitat Ohinata Y, Miller JM, Altschuler RA et al (2000) Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res 878:163–173CrossRef Ohinata Y, Miller JM, Altschuler RA et al (2000) Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea. Brain Res 878:163–173CrossRef
5.
Zurück zum Zitat Oishi N, Schacht J (2011) Emerging treatments for noise-induced hearing loss. Expert Opin Emerg Drugs 16(2):235–245CrossRef Oishi N, Schacht J (2011) Emerging treatments for noise-induced hearing loss. Expert Opin Emerg Drugs 16(2):235–245CrossRef
9.
Zurück zum Zitat Probst R, Tschopp K, Lodin E, Kellerhals B (1992) Michael Podvinec & Carl Rudolf Pfaltz a randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Oto-Laryngologica 112(3):435–443. https://doi.org/10.3109/00016489209137424CrossRef Probst R, Tschopp K, Lodin E, Kellerhals B (1992) Michael Podvinec & Carl Rudolf Pfaltz a randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Oto-Laryngologica 112(3):435–443. https://​doi.​org/​10.​3109/​0001648920913742​4CrossRef
11.
Zurück zum Zitat Le TN, Straatman LV, Lea J, Westerberg B (2017) Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options. J Otolaryngol Head Neck Surg 46(1):41CrossRef Le TN, Straatman LV, Lea J, Westerberg B (2017) Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options. J Otolaryngol Head Neck Surg 46(1):41CrossRef
12.
Zurück zum Zitat Helfer TM, Canham-Chervak M, Canada S, Mitchener TA (2010) Epidemiology of hearing impairment and noise-induced hearing injury among U.S. military personnel, 2003–2005. Am J Prev Med 38(1S):S71–S77 Helfer TM, Canham-Chervak M, Canada S, Mitchener TA (2010) Epidemiology of hearing impairment and noise-induced hearing injury among U.S. military personnel, 2003–2005. Am J Prev Med 38(1S):S71–S77
13.
Zurück zum Zitat Tan CT, Hsu CJ, Lee SY, Liu SH, Lin-Shiau SY (2001) Potentiation of noiseinduced hearing loss by amikacin in guinea pigs. Hear Res 161:72–80CrossRef Tan CT, Hsu CJ, Lee SY, Liu SH, Lin-Shiau SY (2001) Potentiation of noiseinduced hearing loss by amikacin in guinea pigs. Hear Res 161:72–80CrossRef
15.
Zurück zum Zitat Bonfort G, Billot D, Trendel D, Salf E, Lindas P, Barberot JP (2014) Traumatismes sonores aigus: analyse rétrospective de 225 cas militaires [Acute acoustic trauma, a retrospective analysis about 225 military cases]. Rev Laryngol Otol Rhinol (Bord) 135(1):25–31 Bonfort G, Billot D, Trendel D, Salf E, Lindas P, Barberot JP (2014) Traumatismes sonores aigus: analyse rétrospective de 225 cas militaires [Acute acoustic trauma, a retrospective analysis about 225 military cases]. Rev Laryngol Otol Rhinol (Bord) 135(1):25–31
Metadaten
Titel
A Prospective Study to Elucidate the Efficacy of 4 Oral Prednisolone Regimens in Acute Acoustic Trauma
verfasst von
Kamalpreet Singh
Aswini Gude
Amrindarjeet Kour
Mohan Raghav Guthikonda
Awadhesh Kumar Mishra
Arun Gupta
Publikationsdatum
14.02.2021
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 3/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-021-02437-8

Neu im Fachgebiet HNO

ePA: Entlastung oder Mehrarbeit?

Die elektronische Patientenakte (ePA) soll das Gesundheitswesen revolutionieren. Mit über 2000 Krankenhäusern und mehr als 100.000 ärztlichen Praxen ist sie eines der größten Digitalisierungsprojekte Europas. Während die Politik die ePA als „Gamechanger“ feiert, zeigt sich in der Praxis ein anderes Bild.

Fast jeder fünfte Tinnituspatient denkt an Suizid

Von Tinnitus Betroffene schweben in erhöhter Suizidgefahr. Dies ist das Ergebnis einer Studie, wonach sowohl Suizidgedanken wie Versuche der Selbsttötung unter Tinnituspatienten häufiger sind.

Langwirksamer Antikörper bremst chronische Rhinosinusitis

Eine subkutane Injektion mit dem Antikörper Depemokimab alle sechs Monate kann die Beschwerden von Menschen mit ausgeprägter chronischer Rhinosinusitis und Nasenpolypen deutlich lindern. Dafür sprechen die Resultate von zwei Phase-3-Studien.

Kopf-Hals-Tumoren: Die Immuntherapie ist kein Selbstläufer

Ergebnisse einer weiteren Studie legen nahe: Mit einer adjuvanten Immuncheckpointhemmung ist lokal fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereichs nur schwer beizukommen. Einige Fachleute geben die Hoffnung jedoch nicht auf und diskutieren mögliche Gründe für die negativen Ergebnisse.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.